App aims to boost Pill-Taking in hypertension patients
NCT ID NCT05131074
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a mobile app called Collabree to see if it helps people over 50 with high blood pressure take their medication more regularly. 144 participants used the app for 90 days and were followed for another 90 days. The app sent reminders and used behavioral tricks to encourage adherence. Researchers measured pill counts and self-reports to see if the app made a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Collabree mobile phone application (behavioral intervention)
What this could lead to
If successful, this app could help people with high blood pressure take their medication more consistently, improving blood pressure control and reducing health risks.
What could go wrong
This is a small, completed study with 144 participants. The app may not work for everyone, and results might not apply to people who don't use smartphones or have different medication routines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Collabree AG
Zurich, Canton of Zurich, 8002, Switzerland